Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer

Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Study ID
NCT00066391
Phase
PHASE2
Status
Completed

Conditions

  • Penile Cancer

Eligibility Criteria

Sex
MALE
Age
N/A - 75 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy such as irinotecan and cisplatin use different ways to stop tumor cells from dividing so they stop growing or die. Combining irinotecan with cisplatin may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining irinotecan with cisplatin in treating patients who have locally advanced or metastatic penile cancer.

Key Dates

Start date
Jun 30, 2003
Status verified
Sep 2012
Primary completion
Jan 31, 2006

Study Design

Primary purpose
TREATMENT

Primary Outcome Measure

Objective response rate measured by RECIST at 8 weeks after completion of study treatment

Related Studies